Zoetis reported first quarter 2026 revenue of $2.3 billion, up 3% year-over-year, and adjusted EPS of $1.53, missing analyst estimates of $1.61. The performance was impacted by a more challenging U.S. market, while the international segment showed strong growth.
Key Highlights
- U.S. Companion Animal revenue of $865 million fell 11% year-over-year, cited as a result of pet owner price sensitivity, fewer veterinary visits, and heightened competition in dermatology and parasiticides.
- The International segment provided a significant offset, with revenue growing 17% to $1.1 billion, or 10% on an organic operational basis, driven by both companion animal and livestock products.
- Zoetis revised its full year 2026 guidance, lowering its adjusted diluted EPS forecast to a range of $6.85 to $7.00.